<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Endoscopic polypectomy significantly reduces the incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, but recurrence rates are high, especially for <z:mpath ids='MPATH_270'>adenomas</z:mpath> with advanced histology </plain></SENT>
<SENT sid="1" pm="."><plain>The present guidelines recommend re-colonoscopy 3 to 5 years later </plain></SENT>
<SENT sid="2" pm="."><plain>Due to limited resources, more precise predictions of <z:mpath ids='MPATH_270'>adenoma</z:mpath> recurrence are required </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Lesions from 109 patients with colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> recruited into a randomized, placebo-controlled chemoprevention trial with <z:chebi fb="0" ids="6775">mesalazine</z:chebi> were included </plain></SENT>
<SENT sid="4" pm="."><plain>Formalin-fixed paraffin-embedded tissue sections were stained for ß-catenin, cyclooxygenase-2 (Cox-2), and p53 and scored </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_270'>Adenoma</z:mpath> recurrence rates were recorded after 3 years and associated with clinical and immunohistochemical parameters by contingency table analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: After 3 years, <z:mpath ids='MPATH_270'>adenomas</z:mpath> recurred in 51.4 % of patients </plain></SENT>
<SENT sid="7" pm="."><plain>Out of 109 <z:mpath ids='MPATH_270'>adenomas</z:mpath>, 95 met at least one criterion of advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> (size &gt;1 cm, villous histology, high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>) </plain></SENT>
<SENT sid="8" pm="."><plain>There was no influence of age, sex, size or villous histology on <z:mpath ids='MPATH_270'>adenoma</z:mpath> reappearance, whilst the number of <z:mpath ids='MPATH_270'>adenomas</z:mpath> at baseline was positively associated with recurrence (p = 0.003) </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, ß-catenin nuclear localisation, Cox-2 expression and p53 nuclear expression were significantly associated with <z:mpath ids='MPATH_270'>adenoma</z:mpath> recurrence after 3 years (ß-catenin: p = 0.002; Cox-2: p = 0.001; p53: p = 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>Combining these three markers led to a negative predictive value of 88.5 % and a sensitivity of 94.6 % </plain></SENT>
<SENT sid="11" pm="."><plain>(OR = 13.54) CONCLUSIONS: Scoring each single parameter and, more strongly, the combination of <z:hpo ids='HP_0000001'>all</z:hpo> three parameters of the expression of ß-catenin, Cox-2 and p53 in colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> tissue may be a useful negative predictor for <z:mpath ids='MPATH_270'>adenoma</z:mpath> recurrence in patients with advanced colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
</text></document>